Advertisement
Screener

Bellerophon Therapeutics, Inc. Accumulated Other Comprehensive Income

Bellerophon Therapeutics, Inc. Accumulated Other Comprehensive Income

Bellerophon Therapeutics, Inc. had Accumulated Other Comprehensive Income of $0 as of 2018-12-31, per its 10-K filed 2019-03-14.

Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent

us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2019-03-14

  • 2018-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $0.00.
  • 2018-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$1.00K.
  • 2018-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$3.00K.
  • 2018-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$5.00K.
Period endAccumulated Other Comprehensive Income (Loss), Net of Tax
2018-12-31$0.00
10-K · filed 2019-03-14
2018-09-30-$1.00K
10-Q · filed 2018-11-07
2018-06-30-$3.00K
10-Q · filed 2018-08-01
2018-03-31-$5.00K
10-Q · filed 2018-05-10
2017-12-31-$4.00K
10-K · filed 2019-03-14
2017-09-30$0.00
10-Q · filed 2017-11-07
2017-06-30$0.00
10-Q · filed 2017-08-07
2017-03-31$0.00
10-Q · filed 2017-05-15
2016-12-31$0.00
10-K · filed 2018-03-15
2016-09-30-$1.00K
10-Q · filed 2016-11-08
2016-06-30$2.00K
10-Q · filed 2016-08-09
2016-03-31$2.00K
10-Q · filed 2016-05-10
2015-12-31-$19.00K
10-K · filed 2017-03-13
2015-09-30$1.00K
10-Q · filed 2015-11-12